Chemotherapy and Lapatinib or Trastuzumab in Treating Women With HER2/Neu-Positive Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: BIOLOGICAL: trastuzumab|DRUG: docetaxel|DRUG: lapatinib ditosylate|DRUG: paclitaxel
Sponsor: Novartis Pharmaceuticals
Collaborators: NCIC Clinical Trials Group